Arredondo-Alonso S, Blundell-Hunter G, Fu Z, Gladstone R, Fillol-Salom A, Loraine J
Nat Commun. 2023; 14(1):3294.
PMID: 37322051
PMC: 10272209.
DOI: 10.1038/s41467-023-39052-w.
Styles K, Locke R, Cowley L, Brown A, Sagona A
Microbiol Spectr. 2022; 10(3):e0211221.
PMID: 35467398
PMC: 9241782.
DOI: 10.1128/spectrum.02112-21.
Proquot M, Jamal L, Plouzeau-Jayle C, Michaud A, Broutin L, Burucoa C
Microorganisms. 2021; 9(9).
PMID: 34576781
PMC: 8469396.
DOI: 10.3390/microorganisms9091884.
Cress B, Englaender J, He W, Kasper D, Linhardt R, Koffas M
FEMS Microbiol Rev. 2013; 38(4):660-97.
PMID: 24372337
PMC: 4120193.
DOI: 10.1111/1574-6976.12056.
Smajs D, Micenkova L, Smarda J, Vrba M, Sevcikova A, Valisova Z
BMC Microbiol. 2010; 10:288.
PMID: 21078157
PMC: 2995468.
DOI: 10.1186/1471-2180-10-288.
The Escherichia coli argW-dsdCXA genetic island is highly variable, and E. coli K1 strains commonly possess two copies of dsdCXA.
Moritz R, Welch R
J Clin Microbiol. 2006; 44(11):4038-48.
PMID: 17088369
PMC: 1698345.
DOI: 10.1128/JCM.01172-06.
The pathogenicity island-associated K15 capsule determinant exhibits a novel genetic structure and correlates with virulence in uropathogenic Escherichia coli strain 536.
Schneider G, Dobrindt U, Bruggemann H, Nagy G, Janke B, Blum-Oehler G
Infect Immun. 2004; 72(10):5993-6001.
PMID: 15385503
PMC: 517556.
DOI: 10.1128/IAI.72.10.5993-6001.2004.
Preclinical evaluation of group B Neisseria meningitidis and Escherichia coli K92 capsular polysaccharide-protein conjugate vaccines in juvenile rhesus monkeys.
Devi S, Zollinger W, Snoy P, Tai J, Costantini P, Norelli F
Infect Immun. 1997; 65(3):1045-52.
PMID: 9038314
PMC: 175086.
DOI: 10.1128/IAI.65.3.1045-1052.1997.
The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence of an extraintestinal isolate of Escherichia coli.
Russo T, Brown J, Jodush S, Johnson J
Infect Immun. 1996; 64(6):2343-8.
PMID: 8675348
PMC: 174077.
DOI: 10.1128/iai.64.6.2343-2348.1996.
Antigenic phenotypes of Escherichia coli in urine from patients with urinary tract infections.
Miyata H, Kataoka S, Moriguchi N, Yamamoto T, Michibata I, Matui K
Pediatr Nephrol. 1994; 8(3):267-9.
PMID: 7917845
DOI: 10.1007/BF00866327.
Nucleotide sequence and genetic analysis of the neuD and neuB genes in region 2 of the polysialic acid gene cluster of Escherichia coli K1.
Annunziato P, Wright L, Vann W, Silver R
J Bacteriol. 1995; 177(2):312-9.
PMID: 7814319
PMC: 176593.
DOI: 10.1128/jb.177.2.312-319.1995.
Virulence of urinary and faecal Escherichia coli in relation to serotype, haemolysis and haemagglutination.
van den Bosch J, Postma P, Koopman P, de Graaff J, MACLAREN D, van Brenk D
J Hyg (Lond). 1982; 88(3):567-77.
PMID: 7045221
PMC: 2134108.
DOI: 10.1017/s002217240007042x.
Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.
Mattsby-Baltzer I, Hanson L, Olling S, Kaijser B
Infect Immun. 1982; 35(2):647-53.
PMID: 7035370
PMC: 351090.
DOI: 10.1128/iai.35.2.647-653.1982.
Virulence of Escherichia coli strains isolated from urine of patients with acute cystitis and from faeces of healthy women.
van den Bosch J, Postma P, van Brenk D, GUINEE P, de Graaff J, MACLAREN D
Antonie Van Leeuwenhoek. 1981; 47(2):97-106.
PMID: 7020589
DOI: 10.1007/BF02342193.
Colicin V production by clinical isolates of Escherichia coli.
Davies D, Falkiner F, Hardy K
Infect Immun. 1981; 31(2):574-9.
PMID: 7012013
PMC: 351347.
DOI: 10.1128/iai.31.2.574-579.1981.
Chemoattractive factors from Escherichia coli: individual strain variation.
Belsheim J, Gnarpe H, Kaijser B
Infect Immun. 1981; 31(1):7-10.
PMID: 7012007
PMC: 351744.
DOI: 10.1128/iai.31.1.7-10.1981.
Hemagglutination of human type O erythrocytes, hemolysin production, and serogrouping of Escherichia coli isolates from patients with acute pyelonephritis, cystitis, and asymptomatic bacteriuria.
Green C, Thomas V
Infect Immun. 1981; 31(1):309-15.
PMID: 7011993
PMC: 351783.
DOI: 10.1128/iai.31.1.309-315.1981.
Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections.
Evans Jr D, Evans D, Hohne C, Noble M, Haldane E, Lior H
J Clin Microbiol. 1981; 13(1):171-8.
PMID: 7007421
PMC: 273744.
DOI: 10.1128/jcm.13.1.171-178.1981.
Comparative analysis of plasmids and some metabolic characteristics of Escherichia coli K1 from diseased and healthy individuals.
Silver R, AARONSON W, Sutton A, Schneerson R
Infect Immun. 1980; 29(1):200-6.
PMID: 6995336
PMC: 551096.
DOI: 10.1128/iai.29.1.200-206.1980.
Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
Horwitz M, Silverstein S
J Clin Invest. 1980; 65(1):82-94.
PMID: 6985617
PMC: 371342.
DOI: 10.1172/JCI109663.
